logo

Surmodics, Inc (SRDX)



Trade SRDX now with
  Date
  Headline
2/18/2019 8:54:00 AM Surmodics Appoints Timothy Arens As New CFO
1/30/2019 4:11:26 PM Surmodics Q1 EPS $0.09 Vs. Loss $0.12 Year Ago
11/9/2018 7:33:28 AM Surmodics Q4 GAAP Loss Per Share $0.13, Non-GAAP EPS $0.05
11/1/2018 8:30:59 AM Teri Sides Joins Surmodics As SVP And Chief Marketing Officer
8/6/2018 7:33:34 AM Surmodics Q3 GAAP Loss Per Share $0.20, Non-GAAP EPS $0.27
7/31/2018 8:34:45 AM Surmodics IVD Unveils Breakthrough MatrixGuard Diluent
5/16/2018 4:22:33 PM Surmodics Announces Resignation Of Andrew LaFrence As CFO
5/16/2018 4:12:21 PM Biothera Pharmaceuticals Appoints Andrew LaFrence As CFO
5/14/2018 8:31:14 AM Surmodics Acquires Thrombectomy Technology Assets From Embolitech
5/2/2018 7:34:33 AM Surmodics Q2 EPS $0.11 Vs $0.04 Last Year
4/23/2018 8:31:41 AM Surmodics Announces FDA Clearance Of New .018” Low-Profile PTA Balloon Dilation Catheter
2/27/2018 9:02:03 AM Abbott And Surmodics Enter Agreement For Next-Generation Drug-Coated Balloon
2/8/2018 7:31:15 AM Surmodics Q1 Total Revenue $17.0 Mln Vs $17.8 Mln Last Year
1/22/2018 8:07:30 AM Surmodics Gets 510(K) Clearance For Telemark Coronary/Peripheral Support Microcatheter From FDA
7/28/2016 8:41:32 AM SurModics, Inc (SRDX) Has Raised Its FY16 Revenue Estimate To $68.0 - $70.0 Mln From $63.0 - $66.0 Mln
  
 
>